Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2021.1948009
Abstract: ABSTRACT Background Balovaptan is a potent, selective vasopressin 1a receptor antagonist. The early-phase pharmacokinetics (PK) of balovaptan are reported. Research design and methods Two Phase 1 studies (overall N = 93) assessed single- and multiple-dose… read more here.
Keywords: receptor antagonist; day; balovaptan; vasopressin receptor ... See more keywords